GME for Me, GME for Thee, But Watch That Cutter Behind the Tree

As many of you are aware, the exodus from primary care, long and painful, persists despite attempts from professional societies and government to attract new graduates.  The reasons are well known, and solutions, however well intentioned, are cash poor and lack the reorganizational mass to develop a meritable system that balances all medical specialties.

Many institutions rely on trainees to support clinical services, but more importantly, the dollars that complement their presence are a key revenue stream for facilities.

Now that discussions are proceeding in our nation’s capital to reduce the debt, dollars to subsidize training programs are in play, and cuts to federal graduate medical education (GME) dollars are likely.

This is a good opportunity to review what GME is, and how it affects hospitals.

First, for context, here is the federal portion of total health care dollars ($2.2 trillion) allotted for education:

Given the slice is minute, your reaction might be, “why go after training programs?”

The answer is  threefold: 1) it is low hanging fruit and does not impact beneficiaries directly, 2) the health system is thousands of analogous small programs and this is what reductions look like (there are no “home runs”), and 3) the government is doubtless overpaying, or at minimum, subsidizing inefficiently for these services.

Take note, I am not rendering judgment on the number or type of trainees needed, only how hospitals are paid, by how much, and how they utilize it.

For the first two decades after Medicare implementation (1965), training hospitals apportioned their educational costs into charges.  Hospitals billed, and payers paid.  Easy.

That changed in the early 1980’s however, and the government separated these costs, with training hospitals collecting direct and indirect medical education subsidies (DME and IME) to cover training activity expenses.  Hospitals received payments for medical care separately under the prospective payment/DRG system which we utilize today.

We hear these terms, DME and IME, frequently, and to comprehend the intrigues behind proposed cuts, you must understand their distinctions and assumed purpose.

DME:

“[…] is intended to cover Medicare’s share of costs directly related to running GME programs, such as trainees’ salaries; faculty time; administrative costs; and teaching programs’ share of institutional costs of, for example, facilities overhead and malpractice insurance. Medicare assigned hospital-specific per-resident amounts (PRAs) on the basis of cost reports from fiscal year 1983. Although these amounts have been adjusted for inflation, the baseline estimated cost of a resident’s education has not changed in more than 25 years […]”

TranslationDME = PRA x resident quantity x % hospital revenue due to Medicare

IME:

“[…] were intended to reimburse teaching hospitals for the increased costs of patient care related to teaching programs. Never fully elucidated, these costs were believed to involve longer lengths of stay, additional testing, need for more advanced diagnostic and therapeutic modalities, and a more complex mix of patients. The mechanism was an adjustment that teaching hospitals receive to their Medicare billings on the basis of their resident-to-bed ratio […]”

Indirect subsidies comprise a far greater proportion of the total GME payment and currently are at greatest risk of reduction.

Best estimates for breakout costs of trainee education are as follows:

  • Salary = $50,000
  • Benefits= $15,000
  • Training Expense = $50,000

Therefore, the total estimated cost to train one resident is $115,000.

Why then, does MedPAC (the congressional Medicare advisory body) wish to tamper with this seemingly reasonable sum?

Conversely, why does the AAMC (the association for the academic medical community), AHA, and some members of congress object to this potential reduction?

 

 

 

 

 

 

 

 

 

I will address these questions in my next post.

 

 

 

Brad Flansbaum

Bradley Flansbaum, DO, MPH, MHM works for Geisinger Health System in Danville, PA in both the divisions of hospital medicine and population health. He began working as a hospitalist in 1996, at the inception of the hospital medicine movement. He is a founding member of the Society of Hospital Medicine and served as a board member and officer. He speaks nationally in promoting hospital medicine and has presented at many statewide meetings and conferences. He is also actively involved in house staff education.

Currently, he serves on the SHM Public Policy Committee and has an interest in payment policy, healthcare market competition, health disparities, cost-effectiveness analysis, and pain and palliative care. He is SHM’s delegate for the AMA House of Delegates.

Dr. Flansbaum received his undergraduate degree from Union College in Schenectady, NY and attended medical school at the New York College of Osteopathic Medicine. He completed his residency and chief residency in Internal Medicine at Long Island Jewish Medical Center in New York. He received his M.P.H. in Health Policy and Management at Columbia University.

He is a political junky, and loves to cook, stay fit, read non-fiction, listen to many genres of music, and is a resident of Danville, PA.

2 Comments

  1. […] Posted 10/9/11 on The Hospitalist Leader […]

  2. GME Part II | The Hospitalist Leader on October 16, 2011 at 10:54 pm

    […] Skip to content HomeAbout the AuthorsAbout this Blog ← GME for Me, GME for Thee, But Watch That Cutter Behind the Tree […]

Leave a Comment